Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
Xiaona Xie, Xueding Cai, Yemeng Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 12

Showing 12 citing articles:

Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma
Wenjiao Jin, Junming Yu, Yang Su, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2270-2288
Open Access | Times Cited: 11
Anthelmintic Drugs as Emerging Immune Modulators in Cancer
Carmine Stolfi, Teresa Pacifico, Ânderson Luiz-Ferreira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6446-6446
Open Access | Times Cited: 9
Targeting STAT3-Mediated Autophagy with Small Molecules in Cancer Treatment - A Comprehensive Review
S.M. Asadul Karim Azad, Jannatul Naima Meem, A. H. Shaikat, et al.
Deleted Journal (2024), pp. 200174-200174
Open Access | Times Cited: 2
Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer
Yuxin Zhou, Minru Liao, Zixiang Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15121-15121
Open Access | Times Cited: 4
Fluorinated Chitosan‐Mediated Transepithelial Delivery of Intravesical Dual‐Drug Immunotherapeutic for Bladder Cancer Therapy
Lida Feng, Guixiao Huang, Qifang Lei, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 7
Closed Access | Times Cited: 1
Rafoxanide negatively modulates STAT3 and NF‐κB activity and inflammation‐associated colon tumorigenesis
Teresa Pacifico, Carmine Stolfi, Lorenzo Tomassini, et al.
Cancer Science (2024) Vol. 115, Iss. 11, pp. 3596-3611
Open Access | Times Cited: 1
Benzimidazole‐carbamate anthelmintics: Perspective candidates for the anticancer drug development
Parteek Prasher, Mousmee Sharma
Drug Development Research (2022) Vol. 83, Iss. 2, pp. 296-300
Closed Access | Times Cited: 7
Network pharmacology and molecular docking study-based approach to explore mechanism of benzimidazole-based anthelmintics for the treatment of lung cancer
Aakriti Garg, Sonali Karhana, Aysha Bano, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 20, pp. 10739-10760
Closed Access | Times Cited: 2
Cyclodextrin Dispersion of Mebendazole and Flubendazole Improves In Vitro Antiproliferative Activity
Daliana Minda, Alexandra Mioc, Christian Banciu, et al.
Processes (2021) Vol. 9, Iss. 12, pp. 2185-2185
Open Access | Times Cited: 5
Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy
Mingkang Liang, Yongqiang Wang, Lisha Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access
The anticancer mechanisms of Toxoplasma gondii rhoptry protein 16 on lung adenocarcinoma cells
Guangqi Li, Qinhui Li, Yongqing Tong, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Development and evaluation of flubendazole inhalable nanoparticles for lung cancer treatmen
Mariana Yasue Saito Miyagi
(2023)
Open Access
Page 1

Scroll to top